PA8550001A1 - Derivados de acido cicloalquilpirrol-3-carboxilico y derivados de acido heterocicloalquilpirrol-3-carboxilico - Google Patents

Derivados de acido cicloalquilpirrol-3-carboxilico y derivados de acido heterocicloalquilpirrol-3-carboxilico

Info

Publication number
PA8550001A1
PA8550001A1 PA20028550001A PA8550001A PA8550001A1 PA 8550001 A1 PA8550001 A1 PA 8550001A1 PA 20028550001 A PA20028550001 A PA 20028550001A PA 8550001 A PA8550001 A PA 8550001A PA 8550001 A1 PA8550001 A1 PA 8550001A1
Authority
PA
Panama
Prior art keywords
carboxilico
acid derivatives
heterocicloalquilpirrol
cicloalquilpirrol
invention refers
Prior art date
Application number
PA20028550001A
Other languages
English (en)
Inventor
Daniel Yohannes
Xiaojun Liu
George Daniel Maynard
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PA8550001A1 publication Critical patent/PA8550001A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

ESTA INVENCION SE REFIERE A DERIVADOS DE ACIDO CICLOALQUILPIRROL-3-CARBOXILICO Y DERIVADOS DE ACIDO HETEROCICLOALQUILPIRROL-3-CARBOXILICO QUE SE UNEN CON ALTA SELECTIVIDAD Y/O ALTA AFINIDAD AL SITIO DE LA BENZODIAZEPINA DE LOS RECEPTORES GABAA. ESTA INVENCION SE REFIERE TAMBIEN A COMPOSICIONES FARMACEUTICAS QUE COMPRENDEN TALES COMPUESTOS Y AL USO DE TALES COMPUESTOS EN EL TRATAMIENTO DE ENFERMEDADES DEL SISTEMA NERVIOSO CENTRAL (CNS). ESTA INVENCION SE REFIERE TAMBIEN AL USO DE ESTOS DERIVADOS DE ACIDO CICLOALQUILPIRROL-3-CARBOXILICO Y DERIVADOS DE ACIDO HETEROCICLOALQUILPIRROL-3-CARBOXILICO EN COMBINACION CON OTROS AGENTES DEL CNS, UNO O VARIOS, PARA POTENCIAR LOS EFECTOS DE LOS OTROS AGENTES DEL CNS. ADICIONALMENTE, ESTA INVENCION SE REFIERE AL USO DE TALES COMPUESTOS COMO SONDAS PARA LA DETECCION DE LOS RECEPTORES GABAA EN SECCIONES DE TEJIDOS.
PA20028550001A 2001-07-06 2002-07-08 Derivados de acido cicloalquilpirrol-3-carboxilico y derivados de acido heterocicloalquilpirrol-3-carboxilico PA8550001A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30346701P 2001-07-06 2001-07-06

Publications (1)

Publication Number Publication Date
PA8550001A1 true PA8550001A1 (es) 2003-11-12

Family

ID=23172232

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20028550001A PA8550001A1 (es) 2001-07-06 2002-07-08 Derivados de acido cicloalquilpirrol-3-carboxilico y derivados de acido heterocicloalquilpirrol-3-carboxilico

Country Status (13)

Country Link
US (1) US6861529B2 (es)
EP (1) EP1404316A1 (es)
JP (1) JP2004538273A (es)
AP (1) AP2002002579A0 (es)
BR (1) BR0210821A (es)
CA (1) CA2452211A1 (es)
GT (1) GT200200140A (es)
HN (1) HN2002000164A (es)
MX (1) MXPA04000023A (es)
PA (1) PA8550001A1 (es)
PE (1) PE20030187A1 (es)
SV (1) SV2003001147A (es)
WO (1) WO2003004018A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005525333A (ja) 2002-02-07 2005-08-25 ニューロジェン コーポレイション 置換縮合ピラゾールカルボン酸アリールアミド及び関連化合物
US7329288B2 (en) 2004-02-27 2008-02-12 L'oreal S.A. N-heteroaryl secondary para-phenylenediamine, a dye composition comprising such a para-phenylenediamine, a process for preparing this composition and use thereof
EP2480531B1 (en) 2009-09-21 2014-11-05 ChemoCentryx, Inc. Pyrrolidinone carboxamide derivatives as chemerin-r (chemr23) modulators
CA2816957A1 (en) 2010-11-07 2012-05-10 Targegen, Inc. Compositions and methods for treating myelofibrosis
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
WO2017207480A1 (en) 2016-05-30 2017-12-07 Janssen Vaccines & Prevention B.V. Stabilized pre-fusion rsv f proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023265A (en) * 1990-06-01 1991-06-11 Schering Corporation Substituted 1-H-pyrrolopyridine-3-carboxamides
US5750702A (en) * 1993-10-27 1998-05-12 Neurogen Corporation Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands
US5484944A (en) * 1993-10-27 1996-01-16 Neurogen Corporation Certain fused pyrrolecarboxanilides and their use as GABA brain receptor ligands
WO1997034870A1 (en) 1996-03-22 1997-09-25 Neurogen Corporation Certain fused pyrrolecarboxamides as gaba brain receptor ligands
CZ2002614A3 (cs) 1999-08-31 2002-08-14 Neurogen Corporation Kondenzované pyrrolkarboxamidy jako ligandy mozkových GABA-receptorů

Also Published As

Publication number Publication date
HN2002000164A (es) 2002-11-02
US6861529B2 (en) 2005-03-01
SV2003001147A (es) 2003-03-18
CA2452211A1 (en) 2003-01-16
WO2003004018A1 (en) 2003-01-16
MXPA04000023A (es) 2004-05-21
AP2002002579A0 (en) 2002-09-30
US20030069416A1 (en) 2003-04-10
EP1404316A1 (en) 2004-04-07
BR0210821A (pt) 2004-08-31
JP2004538273A (ja) 2004-12-24
PE20030187A1 (es) 2003-03-06
GT200200140A (es) 2003-05-15

Similar Documents

Publication Publication Date Title
ECSP034656A (es) Derivados benzimidazol y piridilimidazol como ligandos para gabaa
UY27380A1 (es) Compuestos de heteroarilo bicíclicos fusionados sustituidos con heteroarilo como ligandos del receptor gabaa
UY26544A1 (es) Antagonistas del factor liberador de corticotropina.
PE20150729A1 (es) 2,3-benzodiazepines
CL2007001555A1 (es) Compuestos derivados de 4-amino-pirido[3,2-e]pirazinas; inhibidores de fosfodiesterasa 10 (pde10); procedimeinto de preparacion; composicion framaceutica; combinacion farmaceutica, y sus uso en el tratamiento de trastornos neurologicos y psiquiatricos, tales como esquizofrenia y otros trastornos psicoticos.
UY28760A1 (es) Compuestos de triazol y su uso como antagonistas del receptor de glutamato metabotrópico
BRPI0519760A2 (pt) derivados de pirrolidila de compostos heteroaromÁticos como inibidores de fosfodiesterasse
NI200900100A (es) Antagonistas de receptor de orexina de diazepan sustituido
CL2011002837A1 (es) Compuestos derivados de 1,2,4-triazolo[4,3-a]piridina, moduladores alostericos positivos de receptores mglur2; composicion farmaceutica; proceso para prepararla; y su uso en el tratamiento o la prevencion de un trastorno del sistema nervioso central tal como la ansiedad, esquizofrenia y migraña, entre otros.
SV2009003048A (es) Pyrido [3,2-e] pyrazines, su uso como inhibidores de la fosfodiestrerasa 10, y los procesos para la preparacion de ellos
ECSP066520A (es) Derivados de dihidrobenzofuranilo alcanamina y métodos para su uso
ECSP066716A (es) Antagonistas del receptor hidroisoindolina taquiquinina
UY27976A1 (es) Piperazinas heterocíclicas sustituídas para el tratamiento de la esquizofrenia
UY28708A1 (es) Heterociclos sustituídos y usos de los mismos
GT200800214A (es) Antagonistas de los piridil amida de los canales de calcios de tipo t
UY28764A1 (es) Compuestos poliheterocíclicos y su uso como antagonistas del receptor de glutamato metabotrópico
UY28720A1 (es) Uso de pteridinas sustituidas para el tratamiento de enfermedades de la vías respiratorias
UY26199A1 (es) Nuevos derivados de benceno, un procedimiento para su preparación y las composiciones farmacéuticas que los contienen
BRPI0415769A (pt) alcanaminas de diidrobenzofuranila e composições farmacêuticas contendo-as
PA8550001A1 (es) Derivados de acido cicloalquilpirrol-3-carboxilico y derivados de acido heterocicloalquilpirrol-3-carboxilico
GT200500319A (es) Algunos metabolitos derivados de [1,4]diazepino[6,7,1-ij]quinolina y metodos para la preparacion y usos de los mismos.
UY29074A1 (es) Heterocíclicos fusionados seleccionados y usos de los mismos
UY27998A1 (es) Piperazinas sustituidas sustituidas heterocíclicas para el tratamiento de la esquizofrenia
DOP2002000430A (es) Derivados de acido cicloalquilprirrol-3-carboxilico y derivados de acido heterocicloalquilpirrol-3-carboxilico.
UY27371A1 (es) Derivados de ácido cicloalquilpirrol-3-carboxílico y derivados de ácido heterocicloalquilpirrol-3-carboxílico